Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tranexamic Acid to Prevent Operation in Chronic Subdural Hematoma
2017-004311-40Phase 3Active
- Sponsor
- Academic Medical Center
- Start
- Mar 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Chronic subdural haematoma (CSDH) comparing Tranexamic acid (Cyclokapron) with Placebo / standard of care (2 arms). Primary endpoint: Surgery requirement for chronic subdural hematoma within 12 weeks. Started Mar 2018; status: active.
02
Drugs
tranexamic acid
03
Conditions
Chronic subdural haematoma (CSDH)
Beyond the preview
Go deeper on 2017-004311-40.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-004311-40.